GlassScriptPhysician profile
Tzvi Bar-David
NPI 1912065996
$38,724.46
in general payments reported to CMS, 2019-2025
8 companies · $11K in 2025
The $11K reported for 2025 was more than what 96% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $3,336 · 2021: $8,689 · 2022: $6,067 · 2023: $2,340 · 2024: $7,304 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Travel and Lodging: $718 · Food and Beverage: $415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,321.50 |
| Travel and Lodging | $718.21 |
| Food and Beverage | $415.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes USA Products LLC | $21,732.26 | 2021-2025 | Na |
| Medical Device Business Services, INC. | $13,009.21 | 2021-2025 | Na |
| Integra Lifesciences Corporation | $3,349.59 | 2019-2020 | |
| Stryker Corporation | $270.10 | 2019-2025 | Na, Variax, Dart-Fire |
| Depuy Synthes Sales INC. | $199.25 | 2021-2022 | |
| Smith+Nephew, INC. | $83.37 | 2021 | |
| Kerecis Limited | $45.91 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Treace Medical Concepts, INC. | $34.77 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tzvi Bar-David listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.